Literature DB >> 29704184

Venous thromboembolism prophylaxis in mental health in-patient services: a qualitative study.

Audrey Purcell1, Mary Clarke2, Ian Maidment3.   

Abstract

Background Venous thromboembolism (VTE) is an important and potentially preventable cause of morbidity and mortality in hospitalised patients. It is a significant, international patient safety issue affecting medical, surgical and mental health in-patients. There is a paucity of published evidence on the incidence of VTE, and the role of VTE risk-assessment and prophylaxis, in mental healthcare settings. Epidemiological evidence indicates that antipsychotic medications are an independent risk factor for VTE. Objective To explore healthcare practitioners' experiences and perspectives regarding VTE prophylaxis for in-patients in mental health services in Ireland. Setting This study was conducted in two national teaching hospitals in Dublin, Ireland. Method This experiential, qualitative study was conducted using face-to-face, semi-structured interviews. Purposive sampling was used to allow strategic selection of participants from the pharmacy, medical and nursing disciplines. Data was analysed using inductive thematic analysis. Consolidated criteria for reporting qualitative studies guidelines were used as a reporting framework. Main outcome measure Participants' views on VTE prophylaxis for mental health in-patients. Results Five key themes were derived: risk factors in mental health, attitudes to risk-assessment, challenges with VTE prophylaxis, lack of awareness, and lack of evidence in mental health. Conclusion The results indicate considerable diversities in perceived risk of VTE, and in experiences with VTE risk-assessment and prophylaxis. VTE risk was considered in practice specifically for immobile, older adults and eating disorder patients on bed rest. Specific research is required to address this area of clinical uncertainty in mental health.

Entities:  

Keywords:  Deep Vein Thrombosis; Ireland; Mental health; Psychiatry; Pulmonary Embolism; Venous thromboembolism

Mesh:

Year:  2018        PMID: 29704184     DOI: 10.1007/s11096-018-0599-7

Source DB:  PubMed          Journal:  Int J Clin Pharm


  13 in total

1.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.

Authors:  Allison Tong; Peter Sainsbury; Jonathan Craig
Journal:  Int J Qual Health Care       Date:  2007-09-14       Impact factor: 2.038

2.  Antipsychotics and venous thromboembolism risk: a meta-analysis.

Authors:  R Zhang; L Dong; F Shao; X Tan; K Ying
Journal:  Pharmacopsychiatry       Date:  2011-07-07       Impact factor: 5.788

3.  A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.

Authors:  S Barbar; F Noventa; V Rossetto; A Ferrari; B Brandolin; M Perlati; E De Bon; D Tormene; A Pagnan; P Prandoni
Journal:  J Thromb Haemost       Date:  2010-11       Impact factor: 5.824

4.  Antipsychotic drugs and risk of venous thromboembolism: nested case-control study.

Authors:  Chris Parker; Carol Coupland; Julia Hippisley-Cox
Journal:  BMJ       Date:  2010-09-21

5.  Incidence of venous thromboembolism in psychiatric units.

Authors:  Aurélien Delluc; Stéphanie Montavon; Olivier Canceil; Marc Carpentier; Emmanuel Nowak; Bernard Mercier; Luc Bressollette; Sylvie Etienne; Michel Walter; Dominique Mottier; Karine Lacut
Journal:  Thromb Res       Date:  2012-10-23       Impact factor: 3.944

Review 6.  Risk of venous thromboembolism during treatment with antipsychotic agents.

Authors:  Jiří Masopust; Radovan Malý; Martin Vališ
Journal:  Psychiatry Clin Neurosci       Date:  2012-12       Impact factor: 5.188

Review 7.  Thrombosis: a major contributor to global disease burden.

Authors:  G E Raskob; P Angchaisuksiri; A N Blanco; H Buller; A Gallus; B J Hunt; E M Hylek; A Kakkar; S V Konstantinides; M McCumber; Y Ozaki; A Wendelboe; J I Weitz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11       Impact factor: 8.311

8.  Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMJ       Date:  2011-08-16

9.  Venous thromboembolism prophylaxis in mental healthcare: do the benefits outweigh the risks?

Authors:  Rashmi Patel
Journal:  BJPsych Bull       Date:  2015-04

10.  Introduction of a Venous Thromboembolism Prophylaxis Protocol for Older Adult Psychiatric Patients.

Authors:  Anna Croxford; Adam Clare; Kathleen McCurdy
Journal:  BMJ Qual Improv Rep       Date:  2015-05-15
View more
  1 in total

Review 1.  The development and validation of a medicines optimisation tool to protect the physical health of people with severe mental illness (OPTIMISE).

Authors:  Aoife Carolan; Dolores Keating; Stephen McWilliams; Caroline Hynes; Mary O'Neill; Fiona Boland; Sharon Holland; Judith Strawbridge; Cristín Ryan
Journal:  BMC Psychiatry       Date:  2022-09-03       Impact factor: 4.144

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.